颗粒溶素

Granulysin, a lytic enzyme, is produced by cytotoxic T lymphocytes during an immune response.
粒细胞溶素是一种溶酶体酶，由杀伤性T淋巴细胞在免疫反应中产生。
The granulysin protein plays a crucial role in the destruction of intracellular pathogens.
粒细胞溶素蛋白在破坏细胞内的病原体中起着关键作用。
Researchers have discovered that certain cancer cells can resist granulysin-induced cell death.
研究人员发现某些癌细胞能抵抗粒细胞溶素诱导的细胞死亡。
Granulysin therapy has shown promise in treating viral infections such as herpes simplex virus.
粒细胞溶素疗法在治疗单纯疱疹病毒等病毒感染方面显示出前景。
In vitro studies demonstrate the potent antimicrobial activity of granulysin against various bacteria.
体外研究显示粒细胞溶素对多种细菌具有强大的抗菌活性。
The release of granulysin by immune cells is tightly regulated to prevent damage to healthy tissues.
免疫细胞释放粒细胞溶素的过程受到严格调控，以防止对健康组织的损害。
Granulysin expression is enhanced in response to viral infections, enhancing the immune system's ability to eliminate infected cells.
在病毒感染时，粒细胞溶素的表达会增强，从而增强免疫系统清除感染细胞的能力。
The combination of granulysin and chemotherapy can improve treatment outcomes for certain types of cancer.
粒细胞溶素与化疗的联合使用可以改善某些类型癌症的治疗效果。
Researchers are exploring the potential of using engineered forms of granulysin as a novel therapeutic approach for autoimmune diseases.
研究人员正在探索改良形式的粒细胞溶素作为治疗自身免疫疾病的新方法。
Granulysin has been found to activate the complement system, which aids in the recruitment of more immune cells to the site of infection.
粒细胞溶素已被发现能激活补体系统，有助于吸引更多免疫细胞到感染部位。